Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

Tomohiro Kubo, MD PhD, Rizwan Romee, MD, John Koreth, MBBS, DPhil, Roger Belizaire, MD PhD, Yusuke Kamihara, MD PhD, Hongye Liu, PhD, Takeru Asano, MDPhD, Jennifer Whangbo, MD PhD, Masahiro Hirakawa, MD PhD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, Corey S. Cutler, MD MPH, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD

Blood (2018) 132 (Supplement 1): 606.

https://doi.org/10.1182/blood-2018-99-109918

Published: 2018

Journal Articles

T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy

Edouard Forcade, MD, Yusuke Kamihara, MD PhD, Haesook T Kim, PhD, Isabelle Douchet, John Koreth, MBBS, DPhil, Masahiro Hirakawa, MD PhD, Corey Cutler, MD MPH, FRCPC, Sarah Nikiforow, MD PhD, Vincent T Ho, MD, Philippe Armand, MD PhD, Edwin Alyea, III, MD, Patrick Blanco, MD PhD, Bruce Blazar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2017) 130 (Supplement 1): 4439.

https://doi.org/10.1182/blood.V130.Suppl_1.4439.4439

Published: 2017

Journal Articles

Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd

Yusuke Kamihara, MD PhD, Edouard Forcade, MD, John Koreth, MBBS, DPhil, Hongye Liu, PhD, Tomohiro Kubo, MD PhD, Jennifer Whangbo, MD PhD, Masahiro Hirakawa, MD PhD, Sarah Nikiforow, MD PhD, Vincent T Ho, MD, Philippe Armand, MD PhD, Corey S. Cutler, MD MPH, Edwin Alyea, III, MD, Bruce Blazar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2017) 130 (Supplement 1): 74.

https://doi.org/10.1182/blood.V130.Suppl_1.74.74

Published: 2017

Journal Articles

Maturation and Phenotypic Diversity of Human CD4 + Regulatory T Cells in Umbilical Cord Blood and Peripheral Blood from Healthy Donors

Tiago R Matos, MD MSc, Hongye Liu, Masahiro Hirakawa, MD PhD, Ana Cristina Alho, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 2357.

https://doi.org/10.1182/blood.V126.23.2357.2357

Published: 2015

Journal Articles

Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities

Benjamin L Lampson, MD PhD, Tiago Matos, MD MSc, Haesook T. Kim, PhD, Siddha Kasar, PhD, Elizabeth A. Morgan, MD, Masahiro Hirakawa, MD PhD, Joshua Fein, Stacey M. Fernandes, Jerome Ritz, MD, Jennifer R. Brown, MD PhD

Blood (2015) 126 (23): 497.

https://doi.org/10.1182/blood.V126.23.497.497

Published: 2015

Journal Articles

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, Edouard Forcade, MD, Kathy S. Wang, PhD, Eduardo L Espada, MD, Jennifer Whangbo, MD PhD, Carol G Reynolds, PhD, Marie J Chammas, Kazuyuki Murase, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 3425.

https://doi.org/10.1182/blood.V126.23.3425.3425

Published: 2015

Journal Articles

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

Tiago R Matos, MD MSc, Benjamin L Lampson, MD PhD, Masahiro Hirakawa, MD PhD, Siddha Kasar, PhD, Stacey M. Fernandes, Jennifer R. Brown, MD PhD, Jerome Ritz, MD

Blood (2015) 126 (23): 1735.

https://doi.org/10.1182/blood.V126.23.1735.1735

Published: 2015

Journal Articles

IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56 bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy

Masahiro Hirakawa, MD PhD, Tiago R Matos, MD MSc, John Koreth, MBBS, DPhil, Edouard Forcade, MD, Jennifer Whangbo, MD PhD, Kazuyuki Murase, MD PhD, Hongye Liu, Sarah Nikiforow, MD PhD, Vincent T Ho, MD, Corey S Cutler, MD MPH, Philippe Armand, MD PhD, Edwin P. Alyea, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD

Blood (2015) 126 (23): 919.

https://doi.org/10.1182/blood.V126.23.919.919

Published: 2015

Journal Articles

Low-Dose IL-2 Reduces Mitochondrial Priming and Increases Bcl2 Expression in CD4 Memory Regulatory T Cells

Kazuyuki Murase, MD PhD, Haesook T. Kim, PhD, Masahiro Hirakawa, MD PhD, Tiago Reis Matos, MD, Yutaka Kawano, MD PhD, Jeremy Ryan, SM, Ken-Ichi Matsuoka, MDPhD, John Koreth, MBBS, DPhil, Robert J Soiffer, MD, Anthony G. Letai, MD PhD, Junji Kato, MD PhD, Jerome Ritz, MD

Blood (2014) 124 (21): 1414.

https://doi.org/10.1182/blood.V124.21.1414.1414

Published: 2014

NARROW

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy

Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd

Maturation and Phenotypic Diversity of Human CD4 + Regulatory T Cells in Umbilical Cord Blood and Peripheral Blood from Healthy Donors

Idelalisib Given Front-Line for the Treatment of Chronic Lymphocytic Leukemia Results in Frequent and Severe Immune-Mediated Toxicities

IL-2, IL-7, IL-15 and IL-6 Induce Differential Activation of Naive and Memory T Cell Subsets

Altered Expression of Functional Proteins in CD4 Regulatory T Cells during Therapy with Idelalisib

IL-2 Induces Selective Activation of Helios-Positive Regulatory T Cells and CD56 bright NK Cells in Vitro and in Patients with Chronic Gvhd Receiving Low-Dose IL-2 Therapy

Low-Dose IL-2 Reduces Mitochondrial Priming and Increases Bcl2 Expression in CD4 Memory Regulatory T Cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only